☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AnnJi
PharmaShots Weekly Snapshots (March 13 - 17, 2023)
March 17, 2023
AnnJi Entered into an Exclusive License Agreement with Avenue Therapeutics to Develop and Commercialize AJ201 for Kennedy's Diseas...
March 13, 2023
Avenue Therapeutics Entered into an Exclusive License Agreement with AnnJi to Develop and Commercialize AJ201 for Spinal and Bulba...
March 3, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.